IT1199374B
(it)
*
|
1984-05-15 |
1988-12-30 |
Alfa Farmaceutici Spa |
Processo per la preparazione di pirido-imidazo-rifamicine
|
IT1264494B1
(it)
*
|
1993-03-23 |
1996-09-24 |
Alfa Wassermann Spa |
Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
|
US7048906B2
(en)
*
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
US6861053B1
(en)
*
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
US5981522A
(en)
*
|
1995-09-01 |
1999-11-09 |
Kaneka Corporation |
Treatment of disease caused by infection of Helicobacter
|
EP0861660B9
(en)
*
|
1997-02-28 |
2006-06-28 |
Kaneka Corporation |
Curative medicine for disease caused by infection of Helicobacter
|
US7122525B2
(en)
*
|
2001-11-21 |
2006-10-17 |
Activbiotics, Inc. |
Targeted therapeutics and uses thereof
|
US7078399B2
(en)
*
|
2001-12-13 |
2006-07-18 |
Activbiotics, Inc. |
Sulfhydryl rifamycins and uses thereof
|
ATE552824T1
(de)
*
|
2002-11-05 |
2012-04-15 |
Fadim S R L |
Kontrollierte und kontinuierliche verabreichung von rifaximin
|
US7820652B2
(en)
*
|
2003-09-24 |
2010-10-26 |
Activbiotics Pharma, Llc |
Regimen for the administration of rifamycin-class antibiotics
|
US7923553B2
(en)
*
|
2003-11-07 |
2011-04-12 |
Alfa Wassermann, S.P.A. |
Processes for the production of polymorphic forms of rifaximin
|
ITMI20032144A1
(it)
*
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
US7906542B2
(en)
*
|
2004-11-04 |
2011-03-15 |
Alfa Wassermann, S.P.A. |
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
|
US7902206B2
(en)
*
|
2003-11-07 |
2011-03-08 |
Alfa Wassermann, S.P.A. |
Polymorphic forms α, β and γ of rifaximin
|
US20080262024A1
(en)
*
|
2003-11-07 |
2008-10-23 |
Giuseppe Claudio Viscomi |
Rifaximin compositions and method of use
|
US7256187B2
(en)
*
|
2004-03-10 |
2007-08-14 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
|
US7265107B2
(en)
*
|
2004-03-10 |
2007-09-04 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
|
US7202246B2
(en)
*
|
2004-06-09 |
2007-04-10 |
Cumbre Pharmaceuticals Inc. |
Spiro-rifamycin derivatives targeting RNA polymerase
|
US20060210492A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
US8003118B2
(en)
*
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
US20060210483A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
DK1698630T3
(da)
*
|
2005-03-03 |
2014-12-08 |
Alfa Wassermann Spa |
Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
|
ITBO20050123A1
(it)
*
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
KR101327635B1
(ko)
|
2005-08-11 |
2013-11-12 |
타간타 테라퓨틱스 인크. |
포스폰산화 리파마이신, 및 그의 뼈 및 관절 감염의 저지및 치료 용도
|
ES2747259T3
(es)
|
2006-03-09 |
2020-03-10 |
Salix Pharmaceuticals Inc |
Preparación anti-disfunción rectal de rifaximina
|
CA2659874C
(en)
|
2006-08-02 |
2016-10-11 |
Salix Pharmaceuticals, Inc. |
Methods for the treatment of radiation proctosigmoiditis
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
EP2069363B1
(en)
*
|
2006-09-22 |
2013-03-20 |
Cipla Ltd. |
Rifaximin in an amorphous form
|
US20080161337A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Chronic Prostatitis
|
US20080159987A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Restless Legs Syndrome
|
ITMI20071241A1
(it)
*
|
2007-06-20 |
2008-12-21 |
Solmag S P A |
Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
|
AU2008273699A1
(en)
|
2007-07-06 |
2009-01-15 |
Lupin Limited |
Pharmaceutical compositions of rifaximin
|
DK2011486T3
(da)
|
2007-07-06 |
2012-09-03 |
Lupin Ltd |
Farmaceutiske sammensætninger af rifaximin
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
US8486956B2
(en)
*
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
CN102015725B
(zh)
|
2008-02-25 |
2014-10-22 |
萨利克斯药品有限公司 |
利福昔明的多种形式及其用途
|
PL2252148T3
(pl)
|
2008-02-26 |
2019-09-30 |
Salix Pharmaceuticals, Ltd. |
Sposoby leczenia zespołu jelita drażliwego
|
US11779571B2
(en)
|
2008-02-26 |
2023-10-10 |
Salix Pharmaceuticals, Inc. |
Methods for treating irritable bowel syndrome (IBS)
|
DK2294012T3
(da)
|
2008-05-07 |
2014-10-06 |
Salix Pharmaceuticals Ltd |
Administration af et tarmrensemiddel og et antibiotika til behandlingen af tarmsygdom
|
US8524691B2
(en)
|
2008-08-13 |
2013-09-03 |
The Medicines Company |
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
|
ES2496190T3
(es)
|
2008-09-26 |
2014-09-18 |
Aska Pharmaceutical Co., Ltd. |
Agente profiláctico y/o terapéutico para trastornos gastrointestinales funcionales
|
SI3628319T1
(sl)
|
2008-10-02 |
2024-04-30 |
Salix Pharmaceuticals, Ltd. |
Zdravljenje jetrne encefalopatije z rifaksiminom
|
JP5756020B2
(ja)
|
2008-12-10 |
2015-07-29 |
シプラ・リミテッド |
リファキシミン複合体
|
IT1397617B1
(it)
*
|
2009-04-20 |
2013-01-18 |
Alfa Wassermann Spa |
Nuovi derivati della rifamicina
|
NZ596851A
(en)
|
2009-06-02 |
2013-10-25 |
Salix Pharmaceuticals Ltd |
Methods of treating hepatic encephalopathy
|
KR20120062897A
(ko)
|
2009-09-13 |
2012-06-14 |
샐릭스 파마슈티컬스 리미티드 |
과민성 장 증후군(ibs)의 치료방법
|
KR20200100215A
(ko)
|
2009-10-27 |
2020-08-25 |
루핀 리미티드 |
리팍시민의 고형 분산물
|
BR112012012316A2
(pt)
|
2009-11-23 |
2016-04-26 |
Cipla Ltd |
composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou ânus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de um silicone e dispensador para composição farmacêutica
|
WO2011080691A1
(en)
|
2009-12-28 |
2011-07-07 |
Silvio Massimo Lavagna |
Method for the production of amorphous rifaximin
|
AU2011218129A1
(en)
|
2010-02-18 |
2012-08-23 |
Board Of Regents Of The University Of Texas System |
Methods for treating infection
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
JP6092629B2
(ja)
|
2010-03-10 |
2017-03-08 |
ルピン・リミテッドLupin Limited |
リファキシミン使用準備済懸濁液
|
CN103228662B
(zh)
|
2010-07-12 |
2016-08-10 |
萨利克斯药品有限公司 |
利福昔明的制剂及其用途
|
US8759513B2
(en)
|
2010-09-13 |
2014-06-24 |
Sequent Scientific Limited |
Polymorphic form of rifaximin and process for its preparation
|
US8735419B2
(en)
|
2011-02-11 |
2014-05-27 |
Salix Pharmaceuticals, Ltd. |
Forms of rifaximin and uses thereof
|
CA2834829A1
(en)
|
2011-05-02 |
2012-11-08 |
Ranbaxy Laboratories Limited |
Rifaximin dimethylformamide solvate
|
ITMI20110890A1
(it)
|
2011-05-19 |
2012-11-20 |
A M S A Anonima Materie Sint & Affini S P A |
Polimorfo di rifaximina e processo per la sua preparazione
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
RU2496475C2
(ru)
|
2011-10-26 |
2013-10-27 |
Александр Васильевич Иващенко |
Фармацевтическая композиция и набор для лечения бактериальных инфекций
|
AU2012332211B2
(en)
|
2011-11-02 |
2016-11-24 |
Salix Pharmaceuticals, Ltd. |
Methods for treating irritable bowel syndrome (IBS) and infections
|
AU2013212008A1
(en)
|
2012-01-25 |
2014-07-10 |
Alfa Wassermann S.P.A. |
Rifaximin derivative and uses thereof
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
US9849090B2
(en)
|
2012-12-12 |
2017-12-26 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical compositions of rifaximin
|
EP2971062A2
(en)
|
2013-03-15 |
2016-01-20 |
ALFA WASSERMANN S.p.A. |
Method for diagnosing vaginal infections
|
US20160038468A1
(en)
|
2013-03-15 |
2016-02-11 |
Alfa Wassermann S.P.A. |
Rifaximin for use in the treating of vaginal infections
|
JP6433980B2
(ja)
|
2013-04-12 |
2018-12-05 |
アルファシグマ ソシエタ ペル アチオニ |
Nsaid投与並びに関連する組成物、方法及びシステム
|
US9018225B1
(en)
|
2013-07-26 |
2015-04-28 |
Novel Laboratories |
Rifaximin crystalline forms and methods of preparation thereof
|
ES2621557T3
(es)
|
2014-03-31 |
2017-07-04 |
Euticals S.P.A. |
Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
|
CA2947962C
(en)
|
2014-05-04 |
2024-01-16 |
Salix Pharmaceuticals, Inc. |
Ibs microbiota and uses thereof
|
ES2742106T3
(es)
|
2014-05-12 |
2020-02-13 |
Alfasigma Spa |
Nueva forma de cristal solvatado de rifaximina, producción, composiciones y usos de la misma
|
EP2982764A1
(en)
|
2014-08-05 |
2016-02-10 |
ALFA WASSERMANN S.p.A. |
Identification of vaginal bacteria
|
US9988398B2
(en)
|
2016-06-07 |
2018-06-05 |
Cadila Healthcare Limited |
Crystalline form of rifaximin and process for its preparation
|
WO2018064472A1
(en)
|
2016-09-30 |
2018-04-05 |
Salix Pharmaceuticals, Ltd. |
Solid dispersion forms of rifaximin
|
IT201700091912A1
(it)
*
|
2017-08-08 |
2019-02-08 |
Biofer Spa |
Nuove pirido-imidazo rifamicine
|
PL3645539T3
(pl)
|
2017-06-26 |
2021-10-25 |
Biofer S.P.A. |
Pochodne pirydoimidazoryfamycyny jako środek przeciwbakteryjny
|